Persantin (Dipyridamole Vials) 5mg/2ml

PERSANTIN (Dipyridamole) 5mg/2ml vials are used for blood flow support in vascular conditions. This injectable formulation aids circulation by widening blood vessels. Ideal for short-term therapy under medical supervision. Prescription required.

Strength

5mg/2ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Boehringer Ingelheim

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PERSANTIN (Dipyridamole) 5mg/2ml vials are primarily used to improve blood flow in conditions like peripheral vascular disease or after heart valve surgery. It helps prevent blood clots by reducing platelet stickiness. Often prescribed alongside other medications for enhanced circulation support. Not a first-line treatment for all vascular issues.

Side Effects

PERSANTIN (Dipyridamole) 5mg/2ml vials may cause mild flushing or dizziness shortly after administration due to its vasodilating properties. Some users report temporary headaches or nausea as the body adjusts. These effects are usually short-lived and subside without intervention. Rarely, it may lower blood pressure slightly.

Precautions & Warnings

Store PERSANTIN (Dipyridamole) 5mg/2ml vials at room temperature, away from direct light and moisture. Keep out of reach of children and pets. Avoid freezing or excessive heat. Inspect the vial for particles or discoloration before use. Discard any unused portion after opening as directed.

Avoid Interactions

PERSANTIN (Dipyridamole) may interact with blood thinners like warfarin or antiplatelet drugs such as aspirin, increasing bleeding risk. Caffeine and certain xanthines may reduce its effectiveness. Alcohol can amplify dizziness or drowsiness. Always disclose all medications to your healthcare provider before use.

Frequently Asked Questions

It is used to improve blood flow in vascular conditions or after heart valve surgery by widening blood vessels.

It is given as an injection by a healthcare professional, typically into a vein.

Yes, mild dizziness or flushing may occur shortly after administration due to its vasodilating effects.

It may interact with blood thinners; consult your doctor before combining medications.

Store at room temperature, away from light and moisture, and discard any unused portion after opening.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.